<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>A computational insight of the improved nicotine binding with ACE2-SARS-CoV-2 complex with its clinical impact · HackerPapers discussions</title><link>https://hackerpaper.kaipfister.de/p/2004.14943/</link><description>Collected HN comments and submissions linking this paper.</description><language>en</language><lastBuildDate>Mon, 02 Nov 2026 11:16:22 GMT</lastBuildDate><atom:link href="https://hackerpaper.kaipfister.de/p/2004.14943/feed.xml" rel="self" type="application/rss+xml" /><item><title>A computational insight of the improved nicotine binding with ACE2-SARS-CoV-2 complex with its clinical impact — mentioned by metrokoi</title><link>https://news.ycombinator.com/item?id=23854997</link><guid isPermaLink="false">urn:hackerpapers:mention:2004.14943:23854997</guid><pubDate>Thu, 16 Jul 2020 02:12:21 GMT</pubDate><description>&lt;p&gt;Smoking decreases the amount of certain enzymes that COVID binds to in order to infect the lungs. Less enzymes means a lesser chance of catching the virus, but if caught, the person will likely have a more severe case due to the decreased lung capability.[0][1] The figures that I have seen previously did show a very significantly decreased risk of catching COVID, and I&amp;#x27;m surprised it hasn&amp;#x27;t been investigated far more. Edit: I had that wrong, it seems nicotine increases ACE2, but also binds with ACE2 decreasing the amount of available enzymes overall that COVID could bind to.[2]…&lt;/p&gt;&lt;p&gt;&lt;a href="https://hackerpaper.kaipfister.de/p/2004.14943/"&gt;Paper and discussion history&lt;/a&gt;. A mention is not an endorsement.&lt;/p&gt;</description><category>q-bio.BM</category></item></channel></rss>
